In recent years, advances in genetic testing have revolutionized our understanding of cancer risk, enabling oncologists to tailor treatments and...

In a groundbreaking study published in Nature, researchers at Cold Spring Harbor Laboratory (CSHL) have unveiled a remarkable connection between...

Diffuse large B-cell lymphoma (DLBCL), an aggressive form of blood cancer, currently poses significant treatment challenges, especially among older patients...

In the complex landscape of end-of-life (EOL) care for patients with advanced cancer, a critical factor that often goes underexamined...

In a groundbreaking leap for cancer research, a team of scientists has successfully engineered a sophisticated 3D pentaculture model that...

Chronic inflammation has long been recognized as a pivotal contributor to cancer development, yet the mechanistic pathways bridging persistent inflammatory...

A groundbreaking study conducted by the Garvan Institute of Medical Research has unveiled the most intricate cellular map of early-stage...

In a groundbreaking study published in the British Journal of Cancer this March, researchers have unveiled compelling insights into how...

In the evolving landscape of cancer treatment, type I interferons (IFNs) have emerged as pivotal players in modulating the immune...

In a groundbreaking development presented at the 15th European Breast Cancer Conference (EBCC15) in Barcelona, new evidence has emerged that...